Treatment of spontaneously hypertensive rats small arteries, with disappearance of acetylcholine-induced contractions, although ( SHR ) and Wistar-Kyoto control rats ( WKY ) for at hypertrophy and remodeling of these small least 12 weeks with calcium channel antagonists arteries were not significantly affected by is associated with regression of structural treatment. In WKY rats, treatment had no effect hypertensive changes in the heart and in conduit on either structure or function of small arteries. and small arteries. To establish whether structural These results demonstrate that treatment with the or functional changes of small arteries could be calcium antagonist mibefradil may induce an corrected with shorter periods of specific improvement in altered endothelial function even antihypertensive treatment, SHR and WKY were before regression of cardiovascular hypertrophy treated for 4 weeks with the novel calcium and remodeling takes place under treatment, channel blocker mibefradil. Blood pressure rise indicating that normalization of abnormal small was significantly reduced by mibefradil treatment artery endothelial function in SHR under in SHR to 165 { 1 mm Hg compared to a systolic antihypertensive therapy may be independent of blood pressure of 183 { 2 mm Hg in untreated correction of altered small artery structure. SHR ( P õ.01 ) . Aortic hypertrophy in SHR was ᭧ 1997 American Journal of Hypertension, Ltd. Am slightly reduced by treatment, but small artery J Hypertens 1997; 10:94 -100 hypertrophy in 4 vascular beds ( mesenteric, renal, coronary, and femoral ) was unaffected by KEY WORDS: Nitric oxide, endothelial-dependent administration of mibefradil for 4 weeks. relaxing factor, endothelial-dependent contracting Mibefradil treatment resulted in normalization of factor, resistance arteries, antihypertensive endothelium-dependent relaxation in mesenteric therapy, hypertension.
A studies have shown that some of these changes may regress toward normal under prolonged antihypertensive treatment. [8] [9] [10] [11] [12] [13] [14] Together with structural abnormalirterial structure and function are altered in spontaneously hypertensive rats (SHR). [1] [2] [3] [4] [5] [6] [7] The changes occurring in these vessels may be those that have been called hypertrophic ties present in hypertensive blood vessels, functional remodeling 2, 3 or eutrophic remodeling. [4] [5] [6] Previous changes occur. 15, 16 There is only scant evidence suggesting that antihypertensive treatment is able to correct functional changes as well as structural changes in hypertension, particularly with angiotensin converting acetylcholine-induced endothelium-dependent con-on the interventricular septum. The interventricular artery was followed to the cardiac apex and then the chordae tractions found in vessels from SHR ( unpublished observations, 1996 ) . tendinae and the myocardium were separated and a vessel of 2 mm in length was isolated. For the isolation of In the present investigation we evaluated the shortterm (4 weeks) chronic effects of treatment of SHR and renal cortical arteries, the renal capsule was first removed.
The kidney was sectioned, and a renal artery was disWistar-Kyoto rats (WKY) with a novel nondihydropyridine calcium channel antagonist, (1S, 2S)-2-[2-[[3-(2-sected close to the renal cortex and then followed distally.
A renal arcuate artery of about 2 mm in length was isobenzylimidazolyl)propyl]methylamine]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl-methoxyacetate lated. Mesenteric small arteries were obtained as previously described. 4, 23, 24 Superior mesenteric arteries were dihydrochloride (mibefradil or Ro 40-5967), 20 which has the interest of not only blocking L-type Ca 2/ channels, taken from the part of the mesenteric vascular bed that feeds the jejunum 8 to 10 cm distal to the pylorus. A third but also T-type Ca 2/ channels. 21 This drug had previously been shown to normalize functional changes after long-order branch at 1 mm distance from the intestine and of about 2 mm in length was isolated. The vessels were term (14 weeks) treatment (authors' unpublished observations, 1995) in association with correction of structural mounted as ring preparations on an isometric myograph (Living Systems Instrumentation, Burlington, VT). The changes.
14 Its effects on functional changes present in hypertensive blood vessels, particularly acetylcholine-dissection and mounting were performed in physiological salt solution (PSS) at room temperature. PSS had the folinduced endothelium-dependent contractions, and on the structure of small resistance-sized arteries of the coronary, lowing composition (in mmol/L): NaCl, 120; NaHCO 3 
Animal Experiments Animal experiments were per-Protocol of Study of Small Arteries
After mountformed following the recommendations of the Cana-ing, the vessels were warmed to 37ЊC and allowed to dian Council for Animal Care and were approved by equilibrate in PSS for about 30 min with the vessel interthe Animal Care Committee of the Clinical Research nal circumference set to give a wall tension of 0.2 mN / Institute. SHR and WKY control rats were bought from mm. Then media width was measured using a LeitzTaconic Farms ( Germantown, NY ) , and were received Diavert inverted light microscope ( Wild Leitz, Heeraged 8 weeks. Rats were housed under conditions of brugg, Switzerland ) , at a 3201 magnification at 12 difconstant temperature ( 22ЊC ) and humidity ( 60% ) and ferent sites along the wall, which were then averaged. exposed to a 12-h dark -light cycle. Systolic blood pres-The vessels were then set to L 0 , where L 0 Å 0.9 L 100 and sure was taken every 2 weeks by the tail-cuff method, L 100 is the internal circumference ( calculated from the after warming and under slight restraint, and recorded distance between the wires ) that the vessels would have on a model 7 Grass polygraph ( Grass Medical Instru-had in vivo when relaxed and under a transmural presments, Quincy, MA ) fitted with a 7-P8 preamplifier, sure of 100 mm Hg. After this, the vessels were mainusing a PCPB photoelectric pulse sensor. The average tained in PSS at 37ЊC for a further 90 min. After the rest of three pressure readings was recorded. SHR and WKY period, the vessels were contracted with K-PSS ( PSS in rats were offered, starting at 10 weeks of age and for 4 which Na is replaced by K ) , and two stimulations with weeks, the calcium channel antagonist mibefradil K-PSS containing 10 mmol/L norepinephrine to verify ( kindly provided by Dr J.-P. Clozel, F. Hoffmann-La that they contracted and developed a tension of at least Roche Ltd., Basel, Switzerland ) at a daily oral dose of 1.5 mN /mm. Endothelium-dependent relaxation of 50 mg / kg body weight mixed with powdered chow. mesenteric small arteries was evaluated. Vessels were Controls were untreated SHR and WKY rats run in stimulated with a concentration of methoxamine equivparallel to each treated groups and handled in identical alent to an EC 80 (10 mmol/L), and relaxed with a single fashion. On the day of the experiment, rats were killed maximal dose of acetylcholine ( 10 mmol/L). by decapitation. The heart and a segment of thoracic Analysis of Data The media cross-sectional area of aorta 1.5 cm in length were blotted dry and weighed.
small arteries ( A ) was obtained from the media thickness ( m) and the circumference of vessels (L), all meaPreparation of Small Arteries Coronary, renal arcuate, and femoral arteries were obtained as we have de-sured with the vessel relaxed and under no passive stretch ( wall tension of 0.2 mN /mm) , and calculated scribed previously. 6, 14, 22 The heart and the kidneys were placed in ice-cold Krebs' solution. The rat was then placed as A Å Lm / pm 2 . Using L 0 and the calculated media cross-sectional area, and assuming a constant media in the supine position and the skin of the right hind leg was incised. An artery in the popliteal region of about 2 volume, the standardized media thickness of blood vessels ( at L 0 ) was then calculated. The lumen diameter mm in length was dissected. To dissect coronary vessels, the right ventricle was opened to expose coronary arteries was obtained as L 0 / p. Results are represented as means { SEM. Statistical duced under treatment with mibefradil, reaching the same value as in WKY for the aorta weight normalized comparisons were performed by ANOVA followed by the Newman-Keuls post hoc test. Differences were con-by body weight ( Table 1 ) . sidered statistically significant when P õ.05.
Effect of Treatment on Vascular Structure Small vessels from the coronary, renal ( arcuate arteries ) , mesen-RESULTS teric, and femoral circulations were studied on a myoEffect of Treatment on Body Weight, Blood Pressure, graph under isometric conditions. Treatment of SHR Heart Weight, and Plasma Renin Activity Body with the calcium channel blocker resulted in little weight of SHR, treated or untreated, was significantly change in the structure of small vessels. Only the media lower than that of age-matched WKY ( Table 1 ) , as we of mesenteric arteries exhibited a slight difference behave previously found.
14, 23 The rise in systolic blood tween treated and untreated SHR, at the limit of sigpressure of SHR was blunted by treatment with the nificance ( P õ .07, t test ) . The expected differences in calcium channel blocker mibefradil by 18 mm Hg ( Fig-different small vessels of SHR relative to WKY 6 were ure 1 and Table 1 ) . Blood pressure of WKY rats was found at the level of the lumen diameter ( smaller ) , unaffected by treatment. The weight of the heart and media width ( larger ) , and the media-to-lumen ratio aorta segments were significantly elevated in SHR rela-( larger ) : particularly in mesenteric small arteries, in tive to WKY when normalized by body weight. The which the differences reached statistical significance in absolute and the normalized weight of aorta segments both SHR and SHR treated with mibefradil relative to but not that of the heart of SHR was significantly re-their respective WKY control, to a lesser degree in coronary and femoral arteries, and were not found to be statistically significant in renal cortical small arteries, as depicted in Table 2 .
Effect of Treatment on Vascular Function
Treatment with the calcium channel blocker did not change maximum media stress developed by small arteries ( Table  3 ) . On the other hand, endothelium-dependent responses induced with 10 mmol/L acetylcholine showed presence of contractions in mesenteric arteries from untreated SHR, which could no longer be detected or were significantly reduced in mibefradil-treated SHR ( Figures 2 and 3 ; Table 3 ) . Relaxation of WKY vessels was complete with acetylcholine and no contractions were detected.
DISCUSSION
This study demonstrates that the calcium channel and nonhypertrophic remodeling in SHR small ves-systolic blood pressure elevation in SHR in the short term ( approximately 20 mm Hg ) . We do not know sels, although there is already less aortic hypertrophy. This contrasts with long-term treatment ( 14 weeks ) , whether vascular structure or endothelial function were improved in SHR after short periods of time of which corrects cardiac and small artery hypertrophy.
14 However, already after this relatively short in-treatment with other such agents, as vessels were only examined after 8 weeks of treatment, and at that time terval of treatment ( and even if there is little or no correction of structural changes of small vessels ) , en-interval only endothelial function was studied and shown to have improved. 25, 26 After 14 weeks of treatdothelial function, as evaluated by acetylcholine-induced relaxation of precontracted small arteries, is ment with mibefradil, the structure of small arteries was corrected to a degree that is similar to that normalized in SHR with disappearance of endothelium-dependent contractions elicited by high doses of achieved with the angiotensin I-converting enzyme inhibitor cilazapril in the same study. 14 Simultaneacetylcholine.
Blood pressure did not continue to rise in SHR ously, there was disappearance of endothelium-dependent contractions elicited by high concentrations when treated with mibefradil in this study, similarly to what was observed in a previous long-term study of acetylcholine in SHR small mesenteric arteries under treatment with both mibefradil and cilazapril ( auwith this drug at a similar time period, 14 but no dramatic fall in blood pressure was observed. In other thors' unpublished observations, 1995 ) . The present study demonstrates that correction of altered endostudies, other calcium channel antagonists such as nifedipine 25 have induced comparable lowering of thelial function in SHR precedes correction of struc- 32 and therefore could potentially antagonize the actions of EDCF, resulting in more effective acetylcholine-induced relaxation. However, contractile effects of methoxamine were unaffected, suggesting that there was no residual in vitro effect of the drug given in vivo, thus making it unlikely that the contractile action of EDCF was blocked by a persistent in vitro effect of mibefradil. Rather, this suggests that there was decreased produc- EDCF, as there is currently evidence that nitric oxide generation is not altered in vessels from SHR, although its degradation may be accelerated. 33 Whether tural changes, as it is already found when regression of vascular changes of small arteries has not yet oc-an antioxidant effect of the calcium channel antagonist could contribute to reduce nitric oxide degradacurred, after 4 weeks of mibefradil administration, and despite little difference in systolic blood pressure tion was not examined in this study.
In conclusion, short-term treatment ( 4 weeks ) of with untreated SHR, which present endothelial dysfunction. In contrast to small artery structure, which SHR with mibefradil, a novel calcium channel blocker, results in normalization of endothelium-dependent exhibited minor reversal without achieving statistical significance ( P õ .07 ) , the weight of thoracic aorta, a vascular relaxation at the level of small arteries at a time when blood pressure is only slightly reduced, crude index of conduit artery hypertrophy, experienced a significant regression toward the value of and when regression of vascular hypertrophy in small resistance-sized, which may be found after more pro-WKY rats ( when expressed as relative weight ) . This suggests that conduit artery hypertrophy may depend longed treatment, has not yet occurred. This suggests that improvement of endothelial dysfunction in small differently on determinants of growth of vascular wall components ( whether blood pressure, humoral, local arteries of SHR occurs before reversal of structural alterations. Since this functional improvement occurs growth factors, or intracellular signaling ) than small arteries, and will be favorably affected by treatment of when blood pressure is only slightly lower in treated SHR in comparison to untreated SHR, this may indishorter duration. The mechanism for these differences between conduit and small arteries remains to be established.
The nature of the endothelial abnormalities present in SHR has been the matter of much study, debate, and controversy. Although initial studies suggested that in experimental hypertension, endothelium-dependent relaxation was blunted, 27 it became apparent that in SHR there was release of vasoconstrictor substances from the endothelium, particularly the socalled endothelium-dependent contracting factor (EDCF) . 28 This has been identified as a cyclooxygenase product, probably an endoperoxide. 29 Typically, EDCF release by high concentrations of acetylcholine is inhibited by indomethacin and other prostaglandin synthase inhibitors. 30 We previously showed that the contractions we obtain in our experimental set-up are inhibitable by indomethacin 31 and thus, in this study, the improvement reported may be construed to be a decreased production or contractile effect of EDCF FIGURE 3. Bar graph shows contraction following initial rein vessels from rats treated with the calcium channel laxation, both induced by 10 mmol / L acetylcholine on methoxablocker. This effect of mibefradil could be due to a mine precontracted small arteries. CaCB 
